STEM CELL THERAPIES, GENE-BASED THERAPIES, OPTOGENETICS, AND RETINAL PROSTHETICS: CURRENT STATE AND IMPLICATIONS FOR THE FUTURE

被引:23
作者
Wood, Edward H. [1 ]
Tang, Peter H. [2 ]
De la Huerta, Irina [1 ]
Korot, Edward [3 ]
Muscat, Stephanie [4 ]
Palanker, Daniel A. [2 ]
Williams, George A. [1 ,3 ]
机构
[1] Associated Retinal Consultants, Royal Oak, MI USA
[2] Stanford Univ, Dept Ophthalmol, Hansen Expt Phys Lab, Stanford, CA 94305 USA
[3] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA
[4] Stanford Univ, Stanford, CA 94305 USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2019年 / 39卷 / 05期
关键词
innovation; stem cells; optogenetics; gene therapy; CRISPR; gene editing; retinal prosthetics; future; biotechnology; LEBER CONGENITAL AMAUROSIS; RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; RPE65; MUTATIONS; INTRAVITREAL INJECTION; MICROBIAL RHODOPSINS; MICE; TRANSPLANTATION; RESTORATION; REPAIR;
D O I
10.1097/IAE.0000000000002449
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To review and discuss current innovations and future implications of promising biotechnology and biomedical offerings in the field of retina. We focus on therapies that have already emerged as clinical offerings or are poised to do so. Methods: Literature review and commentary focusing on stem cell therapies, gene-based therapies, optogenetic therapies, and retinal prosthetic devices. Results: The technologies discussed herein are some of the more recent promising biotechnology and biomedical developments within the field of retina. Retinal prosthetic devices and gene-based therapies both have an FDA-approved product for ophthalmology, and many other offerings (including optogenetics) are in the pipeline. Stem cell therapies offer personalized medicine through novel regenerative mechanisms but entail complex ethical and reimbursement challenges. Conclusion: Stem cell therapies, gene-based therapies, optogenetics, and retinal prosthetic devices represent a new era of biotechnological and biomedical progress. These bring new ethical, regulatory, care delivery, and reimbursement challenges. By addressing these issues proactively, we may accelerate delivery of care to patients in a safe, efficient, and value-based manner.
引用
收藏
页码:820 / 835
页数:16
相关论文
共 94 条
[21]   Classification and evolution of type II CRISPR-Cas systems [J].
Chylinski, Krzysztof ;
Makarova, Kira S. ;
Charpentier, Emmanuelle ;
Koonin, Eugene V. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (10) :6091-6105
[22]   Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration [J].
da Cruz, Lyndon ;
Fynes, Kate ;
Georgiadis, Odysseas ;
Kerby, Julie ;
Luo, Yvonne H. ;
Ahmado, Ahmad ;
Vernon, Amanda ;
Daniels, Julie T. ;
Nommiste, Britta ;
Hasan, Shazeen M. ;
Gooljar, Sakina B. ;
Carr, Amanda-Jayne F. ;
Vugler, Anthony ;
Ramsden, Conor M. ;
Bictash, Magda ;
Fenster, Mike ;
Steer, Juliette ;
Harbinson, Tricia ;
Wilbrey, Anna ;
Tufail, Adnan ;
Feng, Gang ;
Whitlock, Mark ;
Robson, Anthony G. ;
Holder, Graham E. ;
Sagoo, Mandeep S. ;
Loudon, Peter T. ;
Whiting, Paul ;
Coffey, Peter J. .
NATURE BIOTECHNOLOGY, 2018, 36 (04) :1-+
[23]   Optogenetics: 10 years of microbial opsins in neuroscience [J].
Deisseroth, Karl .
NATURE NEUROSCIENCE, 2015, 18 (09) :1213-1225
[24]   Leber congenital amaurosis: Genes, proteins and disease mechanisms [J].
den Hollander, Anneke I. ;
Roepman, Ronald ;
Koenekoop, Robert K. ;
Cremers, Frans P. M. .
PROGRESS IN RETINAL AND EYE RESEARCH, 2008, 27 (04) :391-419
[25]   Gene therapy and genome surgery in the retina [J].
DiCarlo, James E. ;
Mahajan, Vinit B. ;
Tsang, Stephen H. .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (06) :2177-2188
[26]   Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness [J].
Doroudchi, M. Mehdi ;
Greenberg, Kenneth P. ;
Liu, Jianwen ;
Silka, Kimberly A. ;
Boyden, Edward S. ;
Lockridge, Jennifer A. ;
Arman, A. Cyrus ;
Janani, Ramesh ;
Boye, Shannon E. ;
Boye, Sanford L. ;
Gordon, Gabriel M. ;
Matteo, Benjamin C. ;
Sampath, Alapakkam P. ;
Hauswirth, William W. ;
Horsager, Alan .
MOLECULAR THERAPY, 2011, 19 (07) :1220-1229
[27]   Optogenetic Engineering of Retinal Ganglion Cells with AAV2.7m8-ChrimsonRtd-Tomato (GS030-DP) Is Well Tolerated and Induces Functional Responses to Light in Non-Human Primates [J].
Douar, Anne M. ;
Bouquet, Celine ;
Pruneau, Didier ;
Chavas, Joel ;
Dalkara, Deniz ;
Duebel, Jens ;
Benosman, Ryad ;
Chenegros, Guillaume ;
Picaud, Serge ;
Sahel, Jose ;
Thomasson, Nitza .
MOLECULAR THERAPY, 2016, 24 :S106-S107
[28]   Characterization of the expression of MHC proteins in human embryonic stem cells [J].
Drukker, M ;
Katz, G ;
Urbach, A ;
Schuldiner, M ;
Markel, G ;
Itskovitz-Eldor, J ;
Reubinoff, B ;
Mandelboim, O ;
Benvenisty, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9864-9869
[29]   Self-organizing optic-cup morphogenesis in three-dimensional culture [J].
Eiraku, Mototsugu ;
Takata, Nozomu ;
Ishibashi, Hiroki ;
Kawada, Masako ;
Sakakura, Eriko ;
Okuda, Satoru ;
Sekiguchi, Kiyotoshi ;
Adachi, Taiji ;
Sasai, Yoshiki .
NATURE, 2011, 472 (7341) :51-U73
[30]   Testing of Semichronically Implanted Retinal Prosthesis by Suprachoroidal-Transretinal Stimulation in Patients with Retinitis Pigmentosa [J].
Fujikado, Takashi ;
Kamei, Motohiro ;
Sakaguchi, Hirokazu ;
Kanda, Hiroyuki ;
Morimoto, Takeshi ;
Ikuno, Yasushi ;
Nishida, Kentaro ;
Kishima, Haruhiko ;
Maruo, Tomoyuki ;
Konoma, Kunihiko ;
Ozawa, Motoki ;
Nishida, Kohji .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (07) :4726-4733